Latest Insider Transactions at Sellas Life Sciences Group, Inc. (SLS)
This section provides a real-time view of insider transactions for Sellas Life Sciences Group, Inc. (SLS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SELLAS Life Sciences Group, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SELLAS Life Sciences Group, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 22
2024
|
John Thomas Burns CFO |
BUY
Grant, award, or other acquisition
|
Direct |
47,000
+31.56%
|
-
|
|
Jan 22
2024
|
Robert L Van Nostrand Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+36.59%
|
-
|
|
Jan 22
2024
|
John Varian Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+36.59%
|
-
|
|
Jan 22
2024
|
Robert Francomano Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+32.83%
|
-
|
|
Jan 22
2024
|
Jane Wasman Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+36.59%
|
-
|
|
Jan 22
2024
|
Katherine Bach Kalin Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+41.38%
|
-
|
|
Jan 22
2024
|
Barbara A Wood EVP, Gen. Counsel, Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+22.99%
|
-
|
|
Jan 22
2024
|
David A Scheinberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+36.18%
|
-
|
|
Jan 22
2024
|
Angelos M. Stergiou President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
159,000
+29.7%
|
-
|
|
Dec 06
2023
|
John Thomas Burns CFO |
SELL
Other acquisition or disposition
|
Direct |
2,929
-5.06%
|
$2,929
$1.08 P/Share
|
|
Dec 06
2023
|
Robert Francomano Chief Commercial Officer |
SELL
Other acquisition or disposition
|
Direct |
1,082
-4.92%
|
$1,082
$1.08 P/Share
|
|
Dec 06
2023
|
Angelos M. Stergiou President and CEO |
SELL
Other acquisition or disposition
|
Direct |
12,268
-5.34%
|
$12,268
$1.08 P/Share
|
|
Dec 06
2023
|
Barbara A Wood EVP, Gen. Counsel, Corp. Sec. |
SELL
Other acquisition or disposition
|
Direct |
4,119
-4.77%
|
$4,119
$1.08 P/Share
|
|
Feb 02
2023
|
Robert Francomano Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+50.0%
|
-
|
|
Feb 02
2023
|
Angelos M. Stergiou President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
58,000
+20.89%
|
-
|
|
Feb 02
2023
|
John Thomas Burns CFO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+28.84%
|
-
|
|
Feb 02
2023
|
Barbara A Wood EVP, Gen. Counsel, Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+20.76%
|
-
|
|
Feb 02
2023
|
Katherine Bach Kalin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+50.0%
|
-
|
|
Feb 02
2023
|
David A Scheinberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+35.3%
|
-
|
|
Feb 02
2023
|
Robert L Van Nostrand Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+36.23%
|
-
|
|
Feb 02
2023
|
Jane Wasman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+36.23%
|
-
|
|
Feb 02
2023
|
John Varian Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+36.23%
|
-
|
|
Dec 05
2022
|
Barbara A Wood EVP, Gen. Counsel, Corp. Sec. |
SELL
Open market or private sale
|
Direct |
2,153
-3.68%
|
$4,306
$2.59 P/Share
|
|
Dec 05
2022
|
John Thomas Burns CFO |
SELL
Open market or private sale
|
Direct |
1,159
-3.8%
|
$2,318
$2.59 P/Share
|
|
Dec 05
2022
|
Angelos M. Stergiou President and CEO |
SELL
Open market or private sale
|
Direct |
6,494
-3.86%
|
$12,988
$2.61 P/Share
|
|
Jan 31
2022
|
John Thomas Burns CFO |
BUY
Grant, award, or other acquisition
|
Direct |
9,600
+26.06%
|
-
|
|
Jan 31
2022
|
David A Scheinberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,900
+47.71%
|
-
|
|
Jan 31
2022
|
Angelos M. Stergiou President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
44,000
+21.04%
|
-
|
|
Jan 31
2022
|
Robert L Van Nostrand Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,900
+50.0%
|
-
|
|
Jan 31
2022
|
John Varian Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,900
+50.0%
|
-
|
|
Jan 31
2022
|
Jane Wasman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,900
+50.0%
|
-
|
|
Jan 31
2022
|
Barbara A Wood EVP, Gen. Counsel, Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
13,000
+19.11%
|
-
|
|
Dec 02
2021
|
John Thomas Burns CFO |
SELL
Open market or private sale
|
Direct |
231
-1.29%
|
$1,386
$6.27 P/Share
|
|
Dec 02
2021
|
Barbara A Wood EVP, Gen. Counsel, Corp. Sec. |
SELL
Open market or private sale
|
Direct |
847
-1.98%
|
$5,082
$6.25 P/Share
|
|
Dec 02
2021
|
Angelos M. Stergiou President and CEO |
SELL
Open market or private sale
|
Direct |
2,120
-1.72%
|
$12,720
$6.25 P/Share
|
|
Mar 04
2021
|
Angelos M. Stergiou President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
19,750
+16.73%
|
-
|
|
Mar 04
2021
|
John Thomas Burns CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,875
+18.25%
|
-
|
|
Mar 04
2021
|
Barbara A Wood EVP, Gen. Counsel, Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
7,875
+19.33%
|
-
|